200 related articles for article (PubMed ID: 20462658)
1. Cutaneous involvement with marginal zone lymphoma.
Gerami P; Wickless SC; Querfeld C; Rosen ST; Kuzel TM; Guitart J
J Am Acad Dermatol; 2010 Jul; 63(1):142-5. PubMed ID: 20462658
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobulin A deficiency.
Wobser M; Kerstan A; Kneitz H; Goebeler M; Kunzmann V; Rosenwald A; Geissinger E
J Cutan Pathol; 2013 Dec; 40(12):1035-41. PubMed ID: 24274426
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases.
Hoefnagel JJ; Vermeer MH; Jansen PM; Heule F; van Voorst Vader PC; Sanders CJ; Gerritsen MJ; Geerts ML; Meijer CJ; Noordijk EM; Willemze R
Arch Dermatol; 2005 Sep; 141(9):1139-45. PubMed ID: 16172311
[TBL] [Abstract][Full Text] [Related]
4. [Marginal zone B-cell lymphoma affecting the skin: histological and phenotypic study of 49 cases].
Bathelier E; Thomas L; Balme B; Coiffier B; Berger F; Ffrench M; Salles G; Dalle S
Ann Dermatol Venereol; 2008 Nov; 135(11):748-52. PubMed ID: 19061653
[TBL] [Abstract][Full Text] [Related]
5. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
6. Symmetrical primary cutaneous marginal zone lymphoma associated with rheumatoid arthritis.
Yildirim FE; Karaduman A; Hürmüz P; Ozyar E; Barişta I; Sağlam A
J Cutan Pathol; 2010 May; 37(5):600-4. PubMed ID: 19674036
[TBL] [Abstract][Full Text] [Related]
7. FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma.
Schreuder MI; Hoefnagel JJ; Jansen PM; van Krieken JH; Willemze R; Hebeda KM
J Pathol; 2005 Feb; 205(3):302-10. PubMed ID: 15682432
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.
Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG
Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808
[TBL] [Abstract][Full Text] [Related]
9. [Splenic marginal zone B-cell lymphoma with epidermotropic skin involvement].
Gómez-de la Fuente E; Villalón LB; Calzado-Villarreal L; Pinedo-Moraleda F; López-Estebaranz JL
Actas Dermosifiliogr; 2012 Jun; 103(5):427-31. PubMed ID: 21885023
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous marginal zone lymphoma with subclinical cutaneous involvement and biclonality.
Edinger JT; Lorenzo CR; Breneman DL; Swerdlow SH
J Cutan Pathol; 2011 Sep; 38(9):724-30. PubMed ID: 21623870
[TBL] [Abstract][Full Text] [Related]
11. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
[TBL] [Abstract][Full Text] [Related]
13. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
14. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous marginal zone B-cell lymphoma.
Tsuji K; Suzuki D; Naito Y; Sato Y; Yoshino T; Iwatsuki K
Eur J Dermatol; 2005; 15(6):480-3. PubMed ID: 16280304
[TBL] [Abstract][Full Text] [Related]
17. Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma.
Senff NJ; Kluin-Nelemans HC; Willemze R
Br J Haematol; 2008 Jul; 142(1):52-6. PubMed ID: 18422781
[TBL] [Abstract][Full Text] [Related]
18. Marginal zone lymphoma with a dual cutaneous and leukemic presentation and an aberrant myeloid-monocytic phenotype.
Keehn CA; Cualing H
J Cutan Pathol; 2006 Mar; 33(3):236-41. PubMed ID: 16466512
[TBL] [Abstract][Full Text] [Related]
19. How I Diagnose Primary Cutaneous Marginal Zone Lymphoma.
Gibson SE; Swerdlow SH
Am J Clin Pathol; 2020 Sep; 154(4):428-449. PubMed ID: 32808967
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
